Can ApoB help with Langlebigkeit?

ApoB is a key protein in LDL and other atherogenic lipoproteins. Elevated ApoB levels are strongly associated with increased cardiovascular disease risk, which is a major determinant of lifespan. Measuring ApoB can provide a more accurate assessment of cardiovascular risk than LDL-C alone, especially in individuals with metabolic issues. However, ApoB itself is not a direct longevity intervention; it is a biomarker. Lifestyle changes (diet, exercise) and medications (statins, PCSK9 inhibitors) that lower ApoB can reduce CVD risk and thus potentially extend healthspan. The evidence is based on observational studies and randomized controlled trials for CVD endpoints, not directly for longevity. DNA tests for ApoB-related genes (e.g., PCSK9, APOB) have limited predictive power and are not diagnostic. Caveat: ApoB testing is a clinical blood test, not a consumer DNA test. Its utility is confined to cardiovascular risk; lifespan extension is not guaranteed.